Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on July 24, 2025

Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …

Humanoid Global Announces Closing of Private Placement
Vancouver, BC, July 24, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (formerly, New Wave Holdings Corp.) (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) is pleased to announce, further to its news releases on June 23, 2025 …

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025 Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025 (GLOBE …

Minerals Technologies Inc. Announces 2025 Second Quarter Financial Results
-- Earnings per Share of $1.44, or $1.55 Excluding Special Items, Up 36% Sequentially -- -- Operating Income of $75 Million, or $79 Million Excluding Special Items, Up 25% Sequentially -- -- Operating Margin of 14.1% of Sales, or 14.9% Excluding Special …

AI Meets the Ocean: CeruleanAI Brings High-Powered Reef Monitoring to the World
CeruleanAI, developed by CRF™, puts fast, affordable, AI-powered reef monitoring into the hands of restoration teams around the world. KEY LARGO, FL, UNITED STATES, July 24, 2025 /EINPresswire.com/ -- What if the best tools for saving coral reefs weren’ …

Rakovina Therapeutics Announces Warrant Exercise Incentive Program
VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company” or “Rakovina”) a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery is …

Crusoe and Tallgrass Announce AI Data Center in Wyoming
DENVER, July 24, 2025 (GLOBE NEWSWIRE) -- Crusoe, the industry’s first vertically integrated AI infrastructure provider, today announced a strategic partnership with Tallgrass to develop a 1.8 gigawatt (GW) AI data center campus located in southeast …

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal; All Other Proposals Required for Merger Were Approved Stockholders are encouraged to vote FOR Proposals 2 and 3 by Calling 1-877-750-8310 (from the U.S. …

Soorty and Haelixa Expand Traceability Partnership to Boost Circularity and Transparency in Global Denim Supply Chains
KARACHI, PAKISTAN, July 24, 2025 /EINPresswire.com/ -- As global regulations tighten around greenwashing and unverified sustainability claims, Soorty, one of Pakistan’s largest vertically integrated denim manufacturers, is reaffirming its leadership in …

Bel Reports Second Quarter and First Half 2025 Results
WEST ORANGE, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the second quarter and first half of 2025. Second Quarter 2025 Highlights Net sales of $168.3 million compared to …

Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated …

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the …

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …

Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …

CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025
Company to share primary endpoint results at 32-Weeks from Extension phase following late-breaking presentations at Alzheimer's Association International Conference® (AAIC) 2025 Conference call and webcast to be held Monday, July 28 at 8:00 AM ET BOSTON, …

Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter …

Teads to Release Second Quarter 2025 Financial Results on August 7, 2025
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Teads Holding Co. (NASDAQ: TEAD), announced today that the company will release its second quarter 2025 results before the market opens on Thursday, August 7, 2025, followed by a conference call at 8:30 a.m. ( …

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 …

Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
MINNEAPOLIS, July 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the first patient has been dosed in VIKTORIA-2, its Phase 3 …

Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq
- Special Meeting of Stockholders to be Held Virtually on September 5, 2025 - - Live Stockholder Fireside Chat to be Scheduled to Answer Frequently Asked Stockholder Questions - - Nasdaq Hearings Panel Meeting Scheduled on August 14, 2025 - SOUTH SAN …